What is RapaPro?
RapaPro contains Rapamycin (also known as Sirolimus), a well-known mTOR inhibitor studied in scientific and research settings for its role in cellular processes, including autophagy and cellular growth. Discovered in soil samples from Easter Island, Rapamycin has been the subject of numerous studies exploring its effects on cells and biological pathways. This product is intended for research purposes only and is not sold for human consumption or therapeutic use.
Key Features
- Contains Sirolimus nanoparticles
- High-quality research-grade product
- 2-3 week delivery to most countries
- 1mg tablets
Product Information
| Unit size | Not applicable (research purposes) |
| Units per container | 50 tablets |
| Amount per tablet | Rapamycin 1mg |
| Other ingredients | Microcrystalline Cellulose, PVPK30, Isopropyl Alcohol, Magnesium Stearate, Poloxamer 188, Di-alpha Tocopherol, Hydroxypropyl Methylcellulose, Polyethylene Glycol, Tartrazine, Methylene Chloride |
How It Works
Rapamycin is involved in inhibiting the mTORC1 pathway, which is known for regulating cellular growth. Research indicates that blocking this pathway may promote autophagy, the process of removing damaged components from cells. These effects have primarily been observed in animal studies, and ongoing research continues to explore their significance in other settings [1].
Storage Instructions
Store RapaPro in a cool, dry place away from direct sunlight and moisture to maintain product stability. Ensure the container is tightly sealed.
Legality and Regulatory Information
Rapamycin is a prescription-only compound in many countries, including the United States, where it is primarily regulated as a pharmaceutical product. In regions like Australia and the European Union, similar regulations apply. Ensure compliance with local laws before purchasing or using this product for research purposes.
Packaging and Presentation
RapaPro is packaged in a box containing 50 film-coated tablets, ensuring protection from moisture and contamination. The tablets are designed for research use and are formulated for easy handling in laboratory environments.
Is RapaPro Right for Your Research?
RapaPro may be suitable for researchers investigating mTOR inhibition and autophagy pathways. If you are conducting studies related to cellular growth or the effects of mTOR inhibitors, RapaPro provides a high-quality research compound. Ensure proper laboratory protocols are followed when handling the product.
Frequently Asked Questions (FAQs)
Q: How does Rapamycin function in research?
A: Rapamycin is primarily studied for its ability to inhibit the mTORC1 pathway, which plays a role in regulating cellular growth and autophagy. It has been widely researched for its effects on cellular processes in various settings.
Q: Can RapaPro be combined with other research compounds?
A: When combining Rapamycin with other compounds in research, it is essential to consider potential interactions. Researchers are advised to follow safety protocols and consult relevant studies before proceeding.
Q: What is the significance of Sirolimus nanoparticles in RapaPro?
A: The nanoparticle formulation is designed to enhance the bioavailability of Rapamycin in research settings, improving absorption in laboratory experiments.
Q: Are there any storage requirements for RapaPro?
A: Store RapaPro in a cool, dry place away from sunlight and moisture to maintain the stability of the tablets.
Q: Is RapaPro legal for research use in my country?
A: Rapamycin is a regulated compound in many regions, including the United States and the European Union. Researchers are advised to check local regulations before purchasing or using RapaPro in their studies.
References
- [1] Harrison DE, et al. Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature. 2009;460(7253):392-395. doi: 10.1038/nature08221
- [2] Mannick JB, et al. mTOR inhibition improves immune function in the elderly. Science Translational Medicine. 2014;6(268):268ra179. doi: 10.1126/scitranslmed.3009892
- [3] Rubinsztein DC, et al. Autophagy and aging. Cell. 2011;146(5):682-695. doi: 10.1016/j.cell.2011.07.030
- [4] Wilkinson JE, et al. Rapamycin slows aging in mice and improves heart function. Journal of Clinical Investigation. 2012;122(1):323-335. doi: 10.1172/JCI46243
Disclaimer
This product is intended for research purposes only and is not for human consumption. It is not intended to diagnose, treat, cure, or prevent any disease. Always consult with a healthcare provider for personalized advice. The information provided is for educational purposes and is not medical advice. Results may vary, and all research should comply with applicable laws and guidelines.
